Aurobindo Eyes Opportunities After Offloading Natrol For $550m
US-Based Nutritionals Firm To Be Sold After Six Years
Aurobindo has agreed to sell its US-based Natrol dietary supplements business at a significant premium to the $132.5m it paid in late 2014, as the Indian firm continues to drive into complex formulations in the US, including injectables and biosimilars.
